May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Cannabinoid CB1 Receptor–Mediated Inhibition of Calcium Signaling in Rat Retinal Ganglion Cells
Author Affiliations & Notes
  • M.R. Lalonde
    Physiology & Biophysics,
    Dalhousie University, Halifax, NS, Canada
  • A.T. E. Hartwick
    Anatomy & Neurobiology,
    Dalhousie University, Halifax, NS, Canada
  • A.–M. Szczesniak
    Pharmacology,
    Dalhousie University, Halifax, NS, Canada
  • K. Stevens
    Physiology & Biophysics,
    Dalhousie University, Halifax, NS, Canada
  • W.H. Baldridge
    Anatomy & Neurobiology and Ophthalmology,
    Dalhousie University, Halifax, NS, Canada
  • S. Barnes
    Physiology & Biophysics and Ophthalmology,
    Dalhousie University, Halifax, NS, Canada
  • M.E. M. Kelly
    Pharmacology and Ophthalmology,
    Dalhousie University, Halifax, NS, Canada
  • Footnotes
    Commercial Relationships  M.R. Lalonde, None; A.T.E. Hartwick, None; A. Szczesniak, None; K. Stevens, None; W.H. Baldridge, None; S. Barnes, None; M.E.M. Kelly, None.
  • Footnotes
    Support  E.A. Baker and CIHR
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2219. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.R. Lalonde, A.T. E. Hartwick, A.–M. Szczesniak, K. Stevens, W.H. Baldridge, S. Barnes, M.E. M. Kelly; Cannabinoid CB1 Receptor–Mediated Inhibition of Calcium Signaling in Rat Retinal Ganglion Cells . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2219.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The cannabinoid CB1 receptor has been identified in the mammalian retina but the role of cannabinoids in visual processing has yet to be fully elucidated. The CB1 receptor agonist, WIN55,212–2, has differential effects on voltage–dependent Ca channels in salamander and goldfish photoreceptors. The present study investigates the actions of CB1 receptor ligands on voltage–dependent Ca channel currents and glutamate–induced Ca2+ influx in rat RGC cultures. Methods: The presence of CB1 receptors in the rat retina was shown via PCR analysis, and immunohistochemistry demonstrated labelling in the RGC layer. Purified RGCs, isolated from neonatal rats using a two step immuno–panning procedure, were used for Ca2+ imaging and whole–cell patch clamping experiments. RGCs were loaded with the ratiometric Ca2+–indicator dye fura–2, and the effect of WIN55,212–2 on [Ca2+]i during exposure to glutamate (100 µM; with 10 µM glycine) was determined. The voltage–clamp technique was used to record high voltage–activated (HVA) Ca channel currents (using barium as charge carrier), and the effect of WIN55,212–2 alone and in the presence of CB1 receptor antagonists (AM 281 and SR141716) was measured. Results: Ca2+–imaging demonstrated that 5µM WIN55,212–2 significantly inhibited glutamate–induced Ca2+ influx in isolated RGCs (62% ± 5% mean influx of initial response, n=16) and that the inhibition was reversible. HVA Ca channel currents recorded with the patch–clamp technique were also significantly reduced by WIN55,212–2 (0.5 µM, 20% ± 6%, n=5; 1 µM, 25% ± 6%, n=4; 5 µM, 51% ± 9%, n=5). Ca channel current reduction produced by 5 µM WIN55,212–2 was inhibited in the presence of CB1 receptor antagonists, AM 281 (0.1 µM, 83% ± 7% remaining, n=4) and SR141716 (0.1 µM, 95% ± 9% remaining, n=5). Conclusions: The CB1 agonist WIN55,212–2 decreased the amplitude of HVA Ca channel current in a purified rat RGC culture. This decrease was blocked by CB1 receptor antagonists AM 281 and SR141716, confirming a selective CB1 receptor–mediated inhibition of Ca channel currents. These results support a role for endogenous cannabinoids in modulating glutamatergic Ca2+ signaling pathways.

Keywords: calcium • ganglion cells • ion channels 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×